Amolyt Pharma’s Eneboparatide Receives the US FDA’s Fast Track Designation for Hypoparathyroidism
Shots: The US FDA has granted fast track designation to the company’s enebop...
Taysha Gene Therapies’ TSHA-102 Receives the US FDA’s Regenerative Medicine Advanced Therapy Designation for Rett Syndrome
Shots: The US FDA granted RMAT designation to TSHA-102 based on safety & effic...
X4 Pharmaceuticals’ Xolremdi Receives the US FDA’s Approval for the Treatment of WHIM Syndrome
Shots: The US FDA has approved Xolremdi (mavorixafor) capsules for treating WHIM s...
Johnson & Johnson’s Sirturo Gains the CHMP’s Positive Opinion to Treat Multidrug-Resistant Tuberculosis
Shots: The CHMP has granted positive opinion to the company’s Sirturo (bedaq...
AstraZeneca’s Truqap Plus Faslodex Receives the CHMP’s Positive Opinion for Treating Breast Cancer
Shots: The CHMP's positive opinion was based on the P-III (
Takeda’s Fruquintinib Gains the CHMP’s Positive Opinion for Previously Treated Metastatic Colorectal Cancer
Shots: The CHMP has granted positive opinion to the company’s fruquintinib (...
